ORIGINAL STUDIES |
|
Kanatbekova Zh.K., Shakhanov A.V., Uryasyev O.M., Nikiforov A.A.
Clinical significance of determining nitric oxide synthesis regulators in chronic obstructive pulmonary disease in comorbidity with arterial hypertension
|
8-14 |
|
Kupaev V.I., Shagurov A.S., Limareva L.V., Tkachenko K.M., Kuritsyna A.P.
The importance of new therapeutic targets for neutrophil inflammation regulation in case of broncho-obstructive pulmonary diseases
|
15-22 |
|
Melekhov A.V., Svetlakov V.I., Nikitin I.G.
The role of breathing biomechanics and diffusing lung capacity in post-COVID dyspnoea formation
|
23-35 |
|
Obukhova A.A., Markov N.V., Zinchenko A.V., Rabik Yu.D., Zaripova Z.A., Skvortsova R.D., Kulikov A.N.
Chronic night hypoxemia in patients with fibrotic interstitial lung diseases
|
36-45 |
|
Evdokimov D.S., Fizikova A.B., Rukavichnikova A.A., Resnyanskaya E.D.
Primary screening of obstructive sleep apnea in patients with acute coronary syndrome
|
46-52 |
|
Sergeeva O.S., Salamatova V.N., Kotova Yu.A., Shevtsov A.N., Shevtsova V.I.
Influence of hyperuricemia at the efficacy of hypolypidemic therapy in patients with chronic forms of ischemic heart disease
|
53-65 |
|
Magamadov I.S., Skorodumova E.A., Kostenko V.A., Pivovarova L.P., Ariskina O.B., Siverina A.V., Skorodumova E.G.
Association of I/D polymorphism of ACE gene with different course of chronic heart failure and myocardial remodeling in patients with coronary heart disease after coronary artery bypass grafting
|
66-75 |
REVIEWS |
|
Budnevsky A.V., Avdeev S.N., Kravchenko A.Ya., Vostrikova K.V.
Oxidative stress in chronic obstructive pulmonary disease: Pathogenetic and clinical aspects
|
76-83 |
|
Karoli N.A.
Achievement of control in patients with bronchial asthma and obesity: Possibilities of bariatric surgery
|
84-96 |
|
Senyushkin D.V., Kupaev V.I.
Systematic review of remote monitoring in patients with chronic obstructive pulmonary disease
|
98-103 |
GUIDELINES FOR PRACTITIONERS |
|
Prozorova G.G., Budnevsky A.V., Chernik T.A.
Mucoactive drugs in the treatment of patients with acute and chronic respiratory pathology
|
104-110 |
|
Dmitrieva D.S., Filatova D.A., Pavlikova E.P., Krasnova T.N., Mershina E.A., Lisitskaya M.V., Trukhanova M.A., Seredenina E.M., Vaipan D.V., Polyakov R.S., Vartanyan E.L., Sinitsyn V.E.
Role of computed tomographic dynamic myocardial perfusion in the diagnosis of functional significance of coronary artery stenosis
|
112-121 |
|
Tatarintseva Z.G., Katushkina Yu.A., Kosmacheva E.D., Babicheva O.V.
Hypokalemia in a patient with heart failure and atrial fibrillation as a predictor of life-threatening arrhythmia
|
122-128 |
|
Katushkina Yu.A., Tatarintseva Z.G., Kosmacheva E.D.
A case of severe euglycemic ketoacidosis arising during dapagliflozin intake
|
129-136 |
LECTURES & REPORTS |
|
Selivanova G.B., Poteshkina N.G.
The importance of choosing a mucoregulator in the treatment of cough in case of upper and lower respiratory tract diseases. Experience of use and perspectives of carbocysteine therapy
|
137-146 |
|
Borisov V.V.
Chronic prostatitis. Clinical lecture No. 3: Basic principles of treatment and prevention
|
148-155 |
|
Tarzimanova A.I.
Atrial fibrillation: Controversial issues of modern classification, new possibilities of diagnostics and treatment
|
156-161 |
Guideline for practitioners |
|
Savlevich E.L., Markus P.V., Angotoeva I.B., Kirichenko I.M., Bessonov K.K.
Causes of pain syndrome in case of oropharynx inflammatory diseases
|
162-168 |
ACTUAL ISSUES OF PHARMACOTHERAPY AND PREVENTIVE TREATMENT |
|
Kupaev V.I., Osipov D.A.
Clinical efficacy of the combination of indacaterol and glycopyrronium bromide in the treatment of chronic obstructive pulmonary disease at smoking cessation stage
|
170-176 |
PAGES OF HISTORY |
|
Abdulganieva D.I., Bombina L.K., Gilemkhanova D.R., Basarkina A.V.
110 years since the introduction to the world of N.K. Goryaev chamber
|
177-180 |
Русский
